Labcorp cuts development outlook for analysis unit as biotech funding crunch persists
Labcorp cuts development outlook for analysis unit as biotech funding crunch persists
Figure Heloc(FIGR_HELOC)$1.03-0.31%
Hyperliquid(HYPE)$73.554.71%Sign in to your account